Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision tag on the study history page updated from v3.6.4 to v3.6.5, indicating a new version of the page rendering.
    Difference
    0.0%
    Check dated 2026-08-08T17:19:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 on the page, indicating a small platform update. No study data or records appear to be altered.
    Difference
    0.0%
    Check dated 2026-07-25T09:27:12.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from v3.6.2 to v3.6.3, indicating a new platform release.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:08.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.6.2 now appears on the page, replacing Revision: v3.6.0. This reflects a deployment update to the ClinicalTrials.gov interface in the Record History view.
    Difference
    0.0%
    Check dated 2026-06-26T23:19:48.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The history adds that the study is no longer recruiting participants, and notes Revision: v3.6.0, replacing the prior v3.5.5 in the revision history.
    Difference
    0.2%
    Check dated 2026-06-12T14:27:09.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing Revision: v3.5.4. This metadata update indicates the site's revision version is current and does not alter the study history content.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.